Healthcare provider profile · identity verified

David V Ives, MD

Internal Medicine · LEXINGTON, MA · NPI 1457399453

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	473	149
Lisinopril	Lisinopril	294	95
Simvastatin	Simvastatin	289	82
Omeprazole	Omeprazole	250	67
Gabapentin	Gabapentin	233	66
Tamsulosin Hcl	Tamsulosin Hcl	223	75
Levothyroxine Sodium	Levothyroxine Sodium	201	57
Amlodipine Besylate	Amlodipine Besylate	180	57
Trazodone Hcl	Trazodone Hcl	179	50
Metformin Hcl	Metformin Hcl	178	40
Losartan Potassium	Losartan Potassium	164	49
Atenolol	Atenolol	163	46
Lorazepam	Lorazepam	155	38
Famotidine	Famotidine	142	35
Hydrochlorothiazide	Hydrochlorothiazide	142	47
Oxycodone Hcl	Oxycodone Hcl	124	22
Metoprolol Succinate	Metoprolol Succinate	123	38
Fluoxetine Hcl	Fluoxetine Hcl	118	28
Celecoxib	Celecoxib	114	33
Trulicity	Dulaglutide	113	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	112	31
Eliquis	Apixaban	100	27
Pravastatin Sodium	Pravastatin Sodium	92	25
Alprazolam	Alprazolam	90	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	84	25
Allopurinol	Allopurinol	83	25
Albuterol Sulfate Hfa	Albuterol Sulfate	81	33
Meloxicam	Meloxicam	81	31
Sertraline Hcl	Sertraline Hcl	81	30
Aripiprazole	Aripiprazole	80	24
Fluticasone Propionate	Fluticasone Propionate	78	23
Venlafaxine Hcl Er	Venlafaxine Hcl	71	21
Clonazepam	Clonazepam	70	13
Duloxetine Hcl	Duloxetine Hcl	63	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	62	18
Carvedilol	Carvedilol	61	16
Montelukast Sodium	Montelukast Sodium	59	19
Synthroid	Levothyroxine Sodium	57	14
Sumatriptan Succinate	Sumatriptan Succinate	47	suppressed
Alendronate Sodium	Alendronate Sodium	45	16
Finasteride	Finasteride	43	13
Pantoprazole Sodium	Pantoprazole Sodium	43	16
Quetiapine Fumarate	Quetiapine Fumarate	43	12
Escitalopram Oxalate	Escitalopram Oxalate	41	14
Glipizide	Glipizide	41	suppressed
Arnuity Ellipta	Fluticasone Furoate	40	11
Methylphenidate Hcl	Methylphenidate Hcl	40	suppressed
Prednisone	Prednisone	40	26
Zolpidem Tartrate	Zolpidem Tartrate	37	11
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	36	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	36	12
Warfarin Sodium	Warfarin Sodium	35	suppressed
Bupropion Hcl Sr	Bupropion Hcl	32	suppressed
Morphine Sulfate Er	Morphine Sulfate	32	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Methylphenidate Er	Methylphenidate Hcl	31	suppressed
Bupropion Xl	Bupropion Hcl	30	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	30	suppressed
Furosemide	Furosemide	30	12
Tramadol Hcl	Tramadol Hcl	30	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	29	12
Ondansetron Odt	Ondansetron	28	suppressed
Oxcarbazepine	Oxcarbazepine	26	suppressed
Clopidogrel	Clopidogrel Bisulfate	25	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Sildenafil Citrate	Sildenafil Citrate	25	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	17
Buspirone Hcl	Buspirone Hcl	23	suppressed
Colchicine	Colchicine	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Metformin Hcl Er	Metformin Hcl	23	suppressed
Olanzapine	Olanzapine	23	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Jardiance	Empagliflozin	22	suppressed
Methenamine Hippurate	Methenamine Hippurate	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Cephalexin	Cephalexin	21	12
Levetiracetam	Levetiracetam	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	12
Fluticasone Propionate Hfa	Fluticasone Propionate	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Diazepam	Diazepam	19	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	19	14
Felodipine Er	Felodipine	18	suppressed
Labetalol Hcl	Labetalol Hcl	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	18	12
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	17	suppressed
Baclofen	Baclofen	17	suppressed
Estradiol	Estradiol	17	suppressed
Tiadylt Er	Diltiazem Hcl	17	suppressed
Torsemide	Torsemide	17	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	16	suppressed
Efavirenz-Emtric-Tenofov Disop	Efavirenz/Emtricit/Tenofovr Df	16	suppressed
Ozempic	Semaglutide	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Spironolactone	Spironolactone	15	suppressed
Sumatriptan	Sumatriptan	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Potassium Chloride	Potassium Chloride	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Azithromycin	Azithromycin	13	12
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Epinephrine	Epinephrine	13	13
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Lithium Carbonate Er	Lithium Carbonate	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Topiramate	Topiramate	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	12	suppressed
Enulose	Lactulose	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Mesalamine	Mesalamine	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Zonisamide	Zonisamide	12	suppressed
Nystatin	Nystatin	11	suppressed
Trospium Chloride	Trospium Chloride	11	suppressed
Valsartan	Valsartan	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error